Shi Wu
- Molecular Medicine top 0.2%
- Epidemiology top 5%
- Pharmacology top 2%
- Infectious Diseases top 5%
- Endocrinology top 1%
- Topics
- Antibiotic Resistance in Bacteria (29 papers)Antibiotics Pharmacokinetics and Efficacy (14 papers)Infections and bacterial resistance (7 papers)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Shi Wu
46 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Molecular Medicine 1.1k
- Epidemiology 496
- Pharmacology 487
- Infectious Diseases 466
- Endocrinology 390
Countries citing papers authored by Shi Wu
This map shows the geographic impact of Shi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Wu more than expected).
Fields of papers citing papers by Shi Wu
This network shows the impact of papers produced by Shi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Wu. The network helps show where Shi Wu may publish in the future.
Co-authorship network of co-authors of Shi Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Shi Wu. A scholar is included among the top collaborators of Shi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Wu. Shi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 3 | |
| 5 | 12 | |
| 6 | 37 | |
| 7 | 3 | |
| 8 | 10 | |
| 9 | 17 | |
| 10 | Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in Chinabreakdown → | 246 |
| 11 | 9 | |
| 12 | 10 | |
| 13 | 197 | |
| 14 | 75 | |
| 15 | 28 | |
| 16 | 37 | |
| 17 | 77 | |
| 18 | 81 | |
| 19 | 75 | |
| 20 | 1 |
About Shi Wu
Shi Wu is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (29 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Infections and bacterial resistance (7 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Applied Microbiology and Biotechnology (294 citations) and Endocrinology (390 citations). Shi Wu has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Fupin Hu, Yan Guo, Demei Zhu, Minggui Wang, Dandan Yin, Yonggui Zheng, Qingyu Shi, Xiaogang Xu, Haihui Huang and Renru Han. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.